Summary
  • Multi-target molecules 42
  • Clinical molecules 0
  • Avg pChEMBL 7.32
Top Co-occurrence Targets
Active Molecules (42)
InChIKey pChEMBL Type Targets Clinical
LFGSEWXATFKDOY 11.5 IC50 2
LLGDPTDZOVKFDU 9.3 Ki 2
AZUHPIPRWNNVET 8.6 IC50 2
HDQZREMSKXWBDD 8.4 IC50 2
UOBYJVFBFSLCTQ 8.4 Kd 2
IAJDHQMVDOYTBK 8.3 IC50 2
VASGGYKYDYEGLH 8.1 Kd 2
LTHKMHZATSPXJT 8.1 IC50 2
RSHAKYUXYPBILY 8.1 IC50 2
ODGAWHHEVLFTOL 8.1 Kd 2
KJJMSPXCDDBQQH 8.0 IC50 2
XIYIXIHBQDGDQZ 8.0 Kd 2
DGOTYTQLPLGHOO 8.0 IC50 2
HUWXYVANKPAVLJ 7.8 IC50 2
DXFOEMZXVYYLGH 7.8 IC50 2
BYYIYLUYDUVZDT 7.7 Kd 2
CFGKBMKFQCQTCD 7.7 IC50 2
CKJYNYKEADDAPQ 7.6 IC50 2
LOAFYOJUBZPIMS 7.5 IC50 2
DVGMHOKYODBDDE 7.5 IC50 2
VKPJSPACCVYHEI 7.4 IC50 2
KUAKTWAFOGVPTF 7.1 IC50 2
RIXNTYNSJXSSCY 7.1 IC50 2
NNNSRTOOTNLZLC 7.1 IC50 2
GVPZRPVQAAJXNU 7.0 IC50 2
MUAGOTOIUSHWFP 7.0 IC50 2
BWWAUBIBIRFGIH 6.5 IC50 2
ZIKZKHLOSYZXCA 6.4 Kd 2
JEUTVNLXGFTXIX 6.4 IC50 2
BJNLEYZJCBQQNV 6.4 IC50 2
UFWAWGFRBDHWLJ 6.4 IC50 2
ZUXXBCGSGVJVMR 6.3 IC50 2
OFYCIMYEZGXNRV 6.3 IC50 2
PEMJIWVJFZGEMI 6.3 IC50 2
LDWPJOSLYTVLDW 6.3 IC50 2
JYIVMQPLCGSFGI 6.3 IC50 2
OKRNLCHFEMYBGU 6.2 IC50 2
AUECKNIWQAGLTA 6.2 IC50 2
UGXJJKIZIYBORF 6.2 IC50 2
CJTQLBDIXKIMDW 6.1 Kd 2
YYHBOQQWMBQASJ 6.1 IC50 2
SDFIBSSAECGDIK 6.1 IC50 2
2D structure